The 19th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. We expect over 650 delegates and 100 presenting companies with additional 20 brief presentations by seed companies. The forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We expect more than 1700 face-to-face meetings to take place throughout the 2 days. The programme will feature a substantial number of plenary panels covering science and BD&L in the main therapeutic areas.